# A Study of the Safety and Antiretroviral Activity of 3BNC117

> **NCT02588586** · PHASE2 · COMPLETED · sponsor: **Rockefeller University** · enrollment: 17 (actual)

## Conditions studied

- HIV-1 Infection

## Interventions

- **DRUG:** 3BNC117
- **OTHER:** Antiretroviral Treatment Interruption

## Key facts

- **NCT ID:** NCT02588586
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2018-02
- **Final completion:** 2018-04
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2021-06-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02588586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02588586, "A Study of the Safety and Antiretroviral Activity of 3BNC117". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02588586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*